Navigation Links
Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill
Date:4/27/2009

WASHINGTON, April 27 /PRNewswire-USNewswire/ -- Lung Cancer Alliance announced that a comprehensive lung cancer research funding bill targeting lung cancer's high mortality rate was introduced with bipartisan support today in the U.S. House of Representatives today.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO)

"We now have legislation authorizing a broad new comprehensive, multi-agency approach to lung cancer in both Houses of Congress. This is a milestone -- the turning point we are all looking for in federal policy on lung cancer," said LCA President and CEO Laurie Fenton Ambrose.

"We are deeply grateful to the bill's primary sponsors, Congresswoman Donna M. Christensen (D-VI) and Congressman Frank A. LoBiondo (R-NJ), for their continuing leadership on this issue," she said.

Congresswomen Christensen, now in her seventh term, is the first female doctor ever elected to the House of Representatives, a member of the powerful Energy and Commerce Committee which has jurisdiction over health policy and chair of the Congressional Black Caucus Health Braintrust.

"The toll of lung cancer is enormous. It is the biggest cancer killer in every ethnic group, taking more lives each year than the next four most common cancers combined," Congresswoman Christensen said. "With over 60% of new cases being diagnosed in people who never smoked or who had already quit, we need to address this disease as a priority with a more comprehensive strategy."

Congressman LoBiondo, in his eighth term, has been a key legislator on transportation, national security and environmental issues.

"There has been some progress in developing treatments and reducing mortality in lung cancer, but much more can and needs to be done," said Congressman LoBiondo. "My family knows firsthand of the toll lung cancer takes, and I believe this added investment into research and treatment is a necessity."

Similar legislation was introduced in the Senate earlier this year by Senator Dianne Feinstein (D-CA) and Senator Sam Brownback (R-KS), who co-chair the Senate Cancer Coalition.

In the 110th Congress, both the House and the Senate passed resolutions urging the administration to make lung cancer research a priority.

The new House and Senate bills, both entitled the Lung Cancer Mortality Reduction Act of 2009, authorize in law a broad comprehensive program that requires all the research related agencies within the Departments of Health and Human Services, Defense and Veterans Administration to coordinate on a strategy for reducing lung cancer's high mortality rate. Annual progress reports to Congress are also required.

The bill calls for $75 million in the first year to launch the program with such sums as may be necessary in the ensuing four years to accomplish the mortality reduction goal.

"When the war on cancer was launched nearly 40 years ago, lung cancer's 5-year survival rate was 13%. Today it is still only 15% and that is unacceptable. What our leaders in Congress are saying with this legislation is, 'We can and must do better,'" said Fenton Ambrose.

Lung Cancer Alliance (www.lungcanceralliance.org) is the only national non-profit organization solely dedicated to patient support and advocacy for the lung cancer community. LCA's mission is to lead the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

    Media Contact:
    Kay Cofrancesco
    kay@lungcanceralliance.org
    202-744-1541



'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Drug May Help Against Inflammatory Breast Cancer
2. Heart, Bone Problems May Follow Prostate Cancer Treatment
3. Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management
4. MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists
5. Prostate cancer therapy increases risk of fractures and cardiovascular-related death
6. Scientists discover how to improve immune response to cancer at Princess Margaret Hospital
7. Statins Guard Against Prostate Cancer
8. Statins may exert influence on prostate cancer growth by reducing inflammation
9. Major statin study reveals several important findings for reducing prostate cancer and disease
10. Mayo Clinic researcher says improved detection of bladder tumors reduces cancer recurrence
11. Robotic approach to urothelial cancer of the kidney proves to be beneficial for patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... 2016 , ... Pregnancy Awareness Month offers a great time to get familiar ... you are ready to have a baby, it’s best to get started before age ... your Personal Conception & Pregnancy Organizer, written for women who plan on becoming pregnant ...
(Date:5/2/2016)... ... May 02, 2016 , ... TeleMedCo™, a ... designed to automate and improve the rapid diagnosis, triage and admission of patients ... platform, application, and mobile experience for the first time at GENBAND’s Perspectives16 conference. ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... EVP and GM Jim Callandrillo and Duane Reed, VP of business development ... Pharmaceutical Business Intelligence and Research Group (PBIRG) General Meeting from May 15-17 ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased to ... Could Transform the Pharma Landscape .” CMS recently proposed a test of alternate payment ... drugs while preserving care provided to beneficiaries. The webinar will review the details of ...
(Date:5/2/2016)... ... 2016 , ... For many artists, the act of blending paint is based ... a science. , Using the new, highly precise METTLER TOLEDO ML204T balance to ... and meaning to his works. What’s more, it has allowed him to recreate these ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 Glycotope GmbH, a ... announces the appointment of Dr. Alfredo Zurlo ... an oncologist with many years clinical experience and a ... His last role was at Mologen AG where he ... Board. Previously Dr. Zurlo held various positions at F ...
(Date:4/28/2016)... 2016   Click here for supplemental information ... DPLO), the nation,s largest independent specialty pharmacy, announced ... to acquire Valley Campus Pharmacy, Inc., doing business ... specialty pharmacy that provides individualized patient care, based ... In 2015, TNH generated approximately $400 million in ...
(Date:4/28/2016)... , April 28, 2016 ... "Global Plastic Surgery Products Market 2016-2020" report ... ) , The global plastic surgery ... of 9.47% during the period 2016-2020. , ,The growing ... leading to the growth of the market. Lasers are ...
Breaking Medicine Technology: